Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Filings indexed 403 across all filing types
Latest filing 2020-03-26 Regulatory Filings
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings
2020-03-26 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC by Pliant Therapeutics, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, risk factors, management, financial data, and the offering terms. This type of filing is specifically related to capital raising and securities registration for public offering. It is not an annual or quarterly report, audit report, earnings release, or any other type of corporate report. It is a registration statement for securities offering, which falls under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full prospectus text, not just an announcement or a brief summary, confirming it is the actual registration statement filing.
2020-03-14 English
Regulatory Filings 2020
Regulatory Filings
2020-03-11 English
Regulatory Filings 2020
Regulatory Filings
2020-01-08 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel to the SEC responding to comments on a Draft Registration Statement on Form S-1 for Pliant Therapeutics, Inc. It discusses amendments to the registration statement, responses to SEC staff comments, and clarifications about licensing agreements and exhibits. The document references the Form S-1 registration process, which is related to securities offerings and IPOs, and is not a financial report, earnings release, or management discussion. It is a regulatory correspondence responding to SEC comments on a registration filing. The document is not the registration statement itself but an amendment response letter. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and correspondence with regulators that do not fit other categories.
2019-07-17 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC by Pliant Therapeutics, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, risk factors, management, financial data, and the offering terms. This type of filing is a registration statement for securities offering, which is a capital raising activity. Therefore, it fits the category of Capital/Financing Update (CAP). It is not an annual or quarterly report, nor an earnings release or other categories listed. The document length and content confirm it is a full registration statement, not just an announcement or certification.
2019-07-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.